Balyasny Asset Management
CHTP

Balyasny Asset Management’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Balyasny Asset Management’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-90,700
Closed -$501K – 893
2014
Q1 		$501K Buy
+90,700
New +$455K 0.01% 536

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Balyasny Asset Management's CHTP Position: Q2 2014 in Review

Balyasny Asset Management sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 90,700 shares — an estimated $501K sold.

Balyasny Asset Management first reported a position in CHTP in Q1 2014 and held it in 1 quarter. The position peaked at $501K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Balyasny Asset Management reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Balyasny Asset Management sold 90,700 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $501K.
  • Balyasny Asset Management first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q1 2014 and held it in 1 quarter.
  • Balyasny Asset Management's CHELSEA THERAPEUTICS INT'L LTD position peaked at $501K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Balyasny Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.